SMTL ID : 7kjs.1

Crystal structure of CDK2/cyclin E in complex with PF-06873600

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.19 Å

Oligo State

hetero-1-1-mer

Ligands

1 x WG1: 6-(difluoromethyl)-8-[(1R,2R)-2-hydroxy-2-methylcyclopentyl]-2-{[1-(methylsulfonyl)piperidin-4-yl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one(Non-covalent)

WG1.1: 16 residues within 4Å: Chain A: I.10, A.31, K.33, E.51, F.80, E.81, F.82, L.83, H.84, Q.85, D.86, K.89, Q.131, N.132, L.134, D.145 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:A.31, A:F.82, A:L.134, A:L.134 Hydrogen bonds: A:L.83, A:L.83, A:D.86, A:K.89 Water bridges: A:D.86, A:Q.131 Salt bridges: A:D.86

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Freeman-Cook, K.D. et al., Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer. J.Med.Chem. (2021)

Release Date

2021-06-23

Peptides

Cyclin-dependent kinase 2: A
G1/S-specific cyclin-E1: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Cyclin-dependent kinase 2

G1/S-specific cyclin-E1

Related Entries With Identical Sequence